PL2807171T3 - Związki heterocykliczne i sposoby ich stosowania - Google Patents
Związki heterocykliczne i sposoby ich stosowaniaInfo
- Publication number
- PL2807171T3 PL2807171T3 PL13741412T PL13741412T PL2807171T3 PL 2807171 T3 PL2807171 T3 PL 2807171T3 PL 13741412 T PL13741412 T PL 13741412T PL 13741412 T PL13741412 T PL 13741412T PL 2807171 T3 PL2807171 T3 PL 2807171T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- heterocyclic compounds
- heterocyclic
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2012900285A AU2012900285A0 (en) | 2012-01-25 | Methods of treatment or prophylaxis | |
PCT/AU2013/000062 WO2013110135A1 (en) | 2012-01-25 | 2013-01-25 | Heterocyclic compounds and methods for their use |
EP13741412.4A EP2807171B1 (en) | 2012-01-25 | 2013-01-25 | Heterocyclic compounds and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2807171T3 true PL2807171T3 (pl) | 2021-01-25 |
Family
ID=48872833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13741412T PL2807171T3 (pl) | 2012-01-25 | 2013-01-25 | Związki heterocykliczne i sposoby ich stosowania |
Country Status (13)
Country | Link |
---|---|
US (1) | US9624234B2 (pl) |
EP (1) | EP2807171B1 (pl) |
JP (1) | JP6073926B2 (pl) |
CN (1) | CN104470930B (pl) |
AU (1) | AU2013202978B2 (pl) |
CA (1) | CA2861233C (pl) |
ES (1) | ES2830023T3 (pl) |
HK (1) | HK1201531A1 (pl) |
NZ (1) | NZ627558A (pl) |
PL (1) | PL2807171T3 (pl) |
PT (1) | PT2807171T (pl) |
WO (1) | WO2013110135A1 (pl) |
ZA (1) | ZA201405257B (pl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013202982C1 (en) | 2012-01-06 | 2017-01-05 | Novartis Ag | Heterocyclic compounds and methods for their use |
PL2807153T3 (pl) | 2012-01-25 | 2020-09-07 | Novartis Ag | Związki heterocykliczne i sposoby ich zastosowania |
NZ630908A (en) | 2013-07-08 | 2017-08-25 | Novartis Ag | Heterocyclic compounds and methods of their use |
CN107001337B (zh) | 2015-01-13 | 2021-05-04 | 诺华股份有限公司 | 作为血管紧张素ii型拮抗剂的吡咯烷衍生物 |
US10308628B2 (en) | 2015-03-12 | 2019-06-04 | Novartis Ag | Heterocyclic compounds and methods for their use |
CN105021735B (zh) * | 2015-07-21 | 2017-09-19 | 中国科学院西北高原生物研究所 | 白刺种子或其提取物中ss和rsMTCA的检测方法 |
US9650338B1 (en) | 2016-07-29 | 2017-05-16 | VDM Biochemicals, Inc. | Opioid antagonist compounds and methods of making and using |
EP3612495B1 (en) | 2017-04-18 | 2022-07-13 | Breakthrough Technologies, LLC | Sulfur production |
WO2019040105A2 (en) * | 2017-08-21 | 2019-02-28 | Acadia Pharmaceuticals Inc. | COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES |
EP3770148A4 (en) * | 2018-03-23 | 2022-01-05 | Beijing Tide Pharmaceutical Co., Ltd. | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION INCLUDING IT AND ITS USE |
CN112313222B (zh) * | 2018-06-19 | 2024-01-26 | 浙江海正药业股份有限公司 | 四氢异喹啉类衍生物、其制备方法及其用途 |
CN110128393B (zh) * | 2019-06-21 | 2022-09-30 | 华侨大学 | 一种取代异香豆素衍生物的制备方法 |
CN113880825A (zh) | 2020-07-01 | 2022-01-04 | 浙江海正药业股份有限公司 | 四氢异喹啉类衍生物的盐、其制备方法及其医药应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3063420D1 (en) * | 1979-03-26 | 1983-07-07 | Takeda Chemical Industries Ltd | Tetrahydroisoquinolines, their production and the compounds and pharmaceutical compositions containing them for use in the prevention or treatment of hypertension |
FR2487829A2 (fr) | 1979-12-07 | 1982-02-05 | Science Union & Cie | Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
FR2470767A1 (fr) * | 1979-12-07 | 1981-06-12 | Science Union & Cie | Nouveaux iminoacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzymes |
DE3134933A1 (de) * | 1981-09-03 | 1983-03-31 | Hoechst Ag, 6230 Frankfurt | "harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente sowie deren verwendung" |
DE3302126A1 (de) * | 1983-01-22 | 1984-07-26 | Boehringer Ingelheim KG, 6507 Ingelheim | Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung |
JPS6216466A (ja) * | 1985-07-16 | 1987-01-24 | Iwaki Seiyaku Kk | テトラヒドロピリジン誘導体 |
US5612360A (en) | 1992-06-03 | 1997-03-18 | Eli Lilly And Company | Angiotensin II antagonists |
US5236934A (en) * | 1992-08-26 | 1993-08-17 | E. I. Du Pont De Nemours And Company | 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders |
US5610165A (en) * | 1994-02-17 | 1997-03-11 | Merck & Co., Inc. | N-acylpiperidine tachykinin antagonists |
JPH0892207A (ja) * | 1994-07-26 | 1996-04-09 | Sankyo Co Ltd | ピロリジン誘導体 |
BE1012622A3 (fr) * | 1999-04-21 | 2001-01-09 | Solvay | Procede pour la separation d'enantiomeres et reactif enantiopur. |
JP4827821B2 (ja) * | 2004-05-26 | 2011-11-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | シンナミド化合物 |
TWI335816B (en) | 2004-05-26 | 2011-01-11 | Eisai R&D Man Co Ltd | Cinnamide compound |
US7612089B2 (en) * | 2004-11-19 | 2009-11-03 | Portola Pharmaceuticals, Inc. | Tetrahydroisoquinolines as factor Xa inhibitors |
ES2425567T3 (es) | 2004-12-24 | 2013-10-16 | Spinifex Pharmaceuticals Pty Ltd | Método de tratamiento o profilaxis |
EP2952185A1 (en) | 2006-03-20 | 2015-12-09 | Spinifex Pharmaceuticals Pty Ltd | Method of treatment or prophylaxis of inflammatory pain |
NZ601383A (en) | 2010-01-19 | 2014-07-25 | Spinifex Pharm Pty Ltd | Methods and compositions for improved nerve conduction velocity |
-
2013
- 2013-01-25 JP JP2014553582A patent/JP6073926B2/ja active Active
- 2013-01-25 WO PCT/AU2013/000062 patent/WO2013110135A1/en active Application Filing
- 2013-01-25 AU AU2013202978A patent/AU2013202978B2/en active Active
- 2013-01-25 NZ NZ627558A patent/NZ627558A/en unknown
- 2013-01-25 CN CN201380016332.2A patent/CN104470930B/zh active Active
- 2013-01-25 EP EP13741412.4A patent/EP2807171B1/en active Active
- 2013-01-25 CA CA2861233A patent/CA2861233C/en active Active
- 2013-01-25 US US14/373,357 patent/US9624234B2/en active Active
- 2013-01-25 PT PT137414124T patent/PT2807171T/pt unknown
- 2013-01-25 ES ES13741412T patent/ES2830023T3/es active Active
- 2013-01-25 PL PL13741412T patent/PL2807171T3/pl unknown
-
2014
- 2014-07-17 ZA ZA2014/05257A patent/ZA201405257B/en unknown
-
2015
- 2015-03-03 HK HK15102121.1A patent/HK1201531A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2861233A1 (en) | 2013-08-01 |
JP2015504901A (ja) | 2015-02-16 |
ZA201405257B (en) | 2016-10-26 |
CA2861233C (en) | 2021-05-04 |
WO2013110135A1 (en) | 2013-08-01 |
CN104470930A (zh) | 2015-03-25 |
EP2807171A1 (en) | 2014-12-03 |
EP2807171B1 (en) | 2020-08-12 |
NZ627558A (en) | 2016-07-29 |
US9624234B2 (en) | 2017-04-18 |
PT2807171T (pt) | 2020-11-03 |
ES2830023T3 (es) | 2021-06-02 |
US20150218180A1 (en) | 2015-08-06 |
AU2013202978B2 (en) | 2016-05-19 |
EP2807171A4 (en) | 2015-10-21 |
CN104470930B (zh) | 2017-02-22 |
HK1201531A1 (en) | 2015-09-04 |
JP6073926B2 (ja) | 2017-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181628T1 (hr) | Spojevi i postupci za njihovu upotrebu | |
HK1207069A1 (en) | Heterocyclic compounds and uses thereof | |
HK1199725A1 (en) | Heterocyclic compounds and uses thereof | |
HK1198475A1 (en) | Heterocyclic compounds and uses thereof | |
HK1198443A1 (en) | Heterocyclic compounds and uses thereof | |
HK1208439A1 (en) | 5-azaindazole compounds and methods of use 5- | |
HK1193561A1 (zh) | 雜環化合物和其用途 | |
HK1201521A1 (en) | Heterocyclic compounds and methods for their use | |
HK1201533A1 (en) | Heterocyclic compounds and methods for their use | |
HK1201531A1 (en) | Heterocyclic compounds and methods for their use | |
EP2938341A4 (en) | Heterocyclic compounds and methods for the use thereof | |
EP2821401A4 (en) | HETEROCYCLIC COMPOUND AND USE THEREOF | |
AP2015008591A0 (en) | Heterocyclic compounds | |
EP2850077A4 (en) | BIOZIDE COMPOUNDS AND METHOD FOR USE THEREOF | |
EP2886546A4 (en) | Heterocyclic compound and use thereof | |
AP3611A (en) | Heterocyclic compounds and their uses | |
HK1206350A1 (en) | 2h-imidazol-4-amine compounds and their use as bace inhibitors 2h--4- bace | |
HK1201270A1 (en) | Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides -5---5-- | |
EP2813508A4 (en) | HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | |
EP2782571A4 (en) | HETEROCYCLIC COMPOUNDS AND USES THEREOF | |
GB201213726D0 (en) | Novel compounds and their use |